Skip to main content
Premium Trial:

Request an Annual Quote

Pyrosequencing Completes Biotage Acquisition

NEW YORK, Oct. 29 (GenomeWeb News) - Pyrosequencing said today it has completed the acquisition of Biotage, which the parties announced Oct. 14.


In the acquisition, Pyrosequencing, of Uppsala, Sweden, said it made a cash payment of 235 million SEK ($30.5 million  ) and took over a mortgage of 36 million SEK for Biotage's Virginia premises.


The acquisition is the second this year for Pyrosequencing. The company acquired Personal Chemistry in September.


The company said it will now have about 275 employees, and also said it will likely change its name to Biotage.



The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.